In conversation with... James Alexander

from Listen to The Lancet Gastroenterology & Hepatology · host The Lancet

James Alexander (Imperial College London) discusses the latest findings from the VIP case-control study, which is investigating COVID-19 vaccine immune responses in immunosuppressed patients with inflammatory bowel disease.

Episode metadata supplied by the publisher feed · Published Oct 6, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

In conversation with... James Alexander

0:00 13:48

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to The Lancet Gastroenterology & Hepatology?

This episode is 13 minutes long.

When was this Listen to The Lancet Gastroenterology & Hepatology episode published?

This episode was published on October 6, 2022.

Can I download this Listen to The Lancet Gastroenterology & Hepatology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!